Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Northwestern University enrols first subject in trial of drug for pericarditis

Northwestern University has enrolled the first subject in a trial of Cardiol Therapeutics' CardiolRx for the recurrence of pericarditis.The post Northwestern University enrols first subject in trial of drug for pericarditis appeared first on Clinical Trials Arena.

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

FULL DISCLOSURE: This is sponsored content for Cardiol Therapeutics. Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) has reached a major milestone with the announcement that the first patient has been enrolled into a Phase III clinical trial for its lead drug candidate, CardiolRx. The trial, referred to as the Phase III MAVERIC trial by Cardiol, saw its first enrollment conducted by Northwestern University in Chicago. The study aims to evaluate …

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Designed to assess the impact of CardiolRx on preventing episodes of recurrent pericarditis, the first patient has been randomized by Northwestern University in Chicago. Based on a successful end-of-Phase II meeting with the US FDA and subject to MAVERIC outcomes, Cardiol believes the results from MAVERIC will support a New Drug Application. Data from Cardiol’s Phase II MAvERIC-Pilot study presented at the American Heart Association Scientific…

Cardiol Therapeutics Enrolls First Patient inPivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Designed to assess the impact of CardiolRx on preventing episodes of recurrent pericarditis, the first patient has been randomized by Northwestern University in Chicago. Based on a successful end-of-Phase II meeting with the US FDA and subject to MAVERIC outcomes, Cardiol believes the results from MAVERIC will support a New Drug Application. Data from Cardiol’s Phase II MAvERIC-Pilot study presented at the American Heart Association Scientific S…